Persistence Market Research

Global Ophthalmic Devices Market Will Reach $2,685.1 Million in 2020: Persistence Market Research

Ophthalmic Devices Market - Global Market Study on Ophthalmic Devices: Asia to Witness Highest Growth by 2020


New York, NY -- (SBWIRE) -- 09/18/2014 -- Persistence Market Research Released New Market Report “Global Market Study on Ophthalmic Devices: Asia to Witness Highest Growth by 2020,” the global ophthalmic devices market was valued at USD 29,171.5 million in 2014 and is expected to grow at a CAGR of 6.5% from 2014 to 2020, to reach an estimated value of USD 42,685.1 million in 2020.

Browse the full Global Market Study on Ophthalmic Devices: Asia to Witness Highest Growth by 2020 report

Globally, the ophthalmic devices market is witnessing significant growth due to increasing prevalence of eye disorders, such as diabetic retinopathy and macular degeneration. In addition, growing global aging population, increasing government initiatives towards healthcare infrastructure in developing countries, and increasing incidence of lifestyle-associated diseases are also driving the growth of the market. However, lack of awareness among people about eye disorders, poor primary healthcare infrastructure, and lack of insurance in developing countries hamper growth of the global ophthalmic devices market. In addition, eye diseases in children are also increasing due to the general lack of awareness.

The global ophthalmic devices market is anticipated to grow from an estimated USD 29,171.5 million in 2014 to USD 42,685.1 million in 2020 at a CAGR of 6.5% during the forecast period.

Age-related eye diseases, such as glaucoma, cataract, diabetic retinopathy, and age-related macular degeneration, are the leading causes of visual impairment and blindness in North America. According to the American Academy of Ophthalmology, approximately 22 million Americans aged 40 and above were affected by cataract and 2.3 million Americans were affected by glaucoma in 2011.

In Europe, increasing prevalence of chronic eye diseases among the rising aging population is becoming a challenge for the European healthcare system. In France, the number of age-related macular degeneration cases was 0.3 million in 2000 and it is anticipated to increase by 0.5 million in 2020.

However, glaucoma, cataract, and diabetic retinopathy are the major causes of blindness in Asia. Cataract can be held responsible for 50% to 80% of all cases of blindness in Southeast Asia. The prevalence of age-related macular degeneration is also increasing in Asia due to increase in life expectancy and rising incidence of diabetes among the younger population. As per the Centre for Eye Research Australia, prevalence of diabetic retinopathy among people ranged between 17% and 22% in India and 43.1% in rural China in 2012.

Johnson & Johnson, Essilor International, Bausch & Lomb Incorporated, Novartis AG, HOYA CORPORATION and Abbott Laboratories, Inc. are some of the major players of ophthalmic devices market.

The ophthalmic devices market is segmented as follows:

Ophthalmic devices market, by type

Vision care devices
Surgery devices
Diagnostic devices

Ophthalmic devices market, by vision care devices

Contact lenses
Spectacle lenses

Ophthalmic devices market, by surgery devices

Cataract surgery devices
Glaucoma surgery devices
Refractive error surgery devices
Vitreoretinal surgery devices

Ophthalmic devices market, by diagnostic devices

Optical coherence tomography scanners
Fundus cameras
Wavefront aberrometers
Corneal topographers
Visual field analyzers
Specular microscopes
Ophthalmic ultrasound imaging systems

Ophthalmic devices market, by Geography

North America






Rest of the World (RoW)

Browse the full report with TOC